You would have to believe that a lot of the selling is from those who bought below $3 or whom took the rights offering at $3. Either way, taking a small profit and moving on. IMO, it really is silly to sell right now without knowing the full details of the commercialization plan. From the last couple months of public information, we already know that ADMP will receive 50% of the deal plus reimbursement from the product that they are making...a pretty damn good deal! Albeit it took over a year to sign said deal...they had been manufacturing and stockpiling product in anticipation of this milestone.
My guess...the full commercialization plan will become public info soon. If nothing else, we will see it in the next 10Q released in Nov. company just raised $40M from the last offering, so they won't need money for a while...lots of milestones coming up and a large payday when the US deal is broken wide open...especially with Mylan struggling to produce. ADMP is in a win-win situation.
Again, IMHO
I'm holding and may add a few more at this $3.35 price. Good luck everyone.
News 
Market Data 
Discover 
AI
